Exploiting ING2 Epigenetic Modulation as a Therapeutic Opportunity for Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) has been the leading cause of cancer-related death worldwide, over the last few decades. Survival remains extremely poor in the metastatic setting and, consequently, innovative therapeutic strategies are urgently needed. Inhibitor of Growth Gene 2 (ING2) is a core...

Descripción completa

Detalles Bibliográficos
Autores principales: Blondel, Alice, Benberghout, Amine, Pedeux, Rémy, Ricordel, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827349/
https://www.ncbi.nlm.nih.gov/pubmed/31640185
http://dx.doi.org/10.3390/cancers11101601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827349/
https://www.ncbi.nlm.nih.gov/pubmed/31640185
http://dx.doi.org/10.3390/cancers11101601

Ejemplares similares